JPWO2021034646A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021034646A5
JPWO2021034646A5 JP2022510108A JP2022510108A JPWO2021034646A5 JP WO2021034646 A5 JPWO2021034646 A5 JP WO2021034646A5 JP 2022510108 A JP2022510108 A JP 2022510108A JP 2022510108 A JP2022510108 A JP 2022510108A JP WO2021034646 A5 JPWO2021034646 A5 JP WO2021034646A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
binding molecule
nos
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022510108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545655A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/046335 external-priority patent/WO2021034646A1/en
Publication of JP2022545655A publication Critical patent/JP2022545655A/ja
Publication of JPWO2021034646A5 publication Critical patent/JPWO2021034646A5/ja
Pending legal-status Critical Current

Links

JP2022510108A 2019-08-17 2020-08-14 多量体の二重特異性抗ｃｄ１２３結合分子及びその使用 Pending JP2022545655A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962888475P 2019-08-17 2019-08-17
US62/888,475 2019-08-17
US201962888702P 2019-08-19 2019-08-19
US62/888,702 2019-08-19
PCT/US2020/046335 WO2021034646A1 (en) 2019-08-17 2020-08-14 Multimeric bispecific anti-cd123 binding molecules and uses thereof

Publications (2)

Publication Number Publication Date
JP2022545655A JP2022545655A (ja) 2022-10-28
JPWO2021034646A5 true JPWO2021034646A5 (zh) 2023-06-16

Family

ID=74659605

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022510108A Pending JP2022545655A (ja) 2019-08-17 2020-08-14 多量体の二重特異性抗ｃｄ１２３結合分子及びその使用

Country Status (11)

Country Link
US (1) US20220289856A1 (zh)
EP (1) EP4013796A4 (zh)
JP (1) JP2022545655A (zh)
KR (1) KR20220045030A (zh)
CN (1) CN114341179A (zh)
AU (1) AU2020334882A1 (zh)
BR (1) BR112022002897A2 (zh)
CA (1) CA3147767A1 (zh)
IL (1) IL289964A (zh)
MX (1) MX2022002024A (zh)
WO (1) WO2021034646A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201608194VA (en) 2014-04-03 2016-10-28 Igm Biosciences Inc Modified j-chain
IL308212A (en) 2015-01-20 2024-01-01 Igm Biosciences Inc Tumor necrosis factor-α receptor binding molecules and their uses
KR102558839B1 (ko) 2015-03-25 2023-07-25 아이쥐엠 바이오사이언스 인코포레이티드 다가 b형 간염 바이러스 항원 결합 분자 및 그의 용도
WO2017059387A1 (en) 2015-09-30 2017-04-06 Igm Biosciences, Inc. Binding molecules with modified j-chain
WO2017059380A1 (en) 2015-09-30 2017-04-06 Igm Biosciences, Inc. Binding molecules with modified j-chain
WO2023012367A1 (en) * 2021-08-06 2023-02-09 Universität Basel Discernible cell surface protein variants for use in cell therapy
TW202325734A (zh) * 2021-09-17 2023-07-01 美商阿迪瑪有限公司 抗cd3抗體

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045774A (en) * 1997-01-10 2000-04-04 Epicyte Pharmaceutical Inc. J chain polypeptide targeting molecule linked to an imaging agent
EP4269441A3 (en) * 2013-08-08 2024-01-24 Cytune Pharma Il-15 and il-15ralpha sushi domain based on modulokines
AU2016210068B2 (en) * 2015-01-23 2021-10-28 Sanofi Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding to CD3 and/or CD123
WO2017059387A1 (en) * 2015-09-30 2017-04-06 Igm Biosciences, Inc. Binding molecules with modified j-chain
WO2017059380A1 (en) * 2015-09-30 2017-04-06 Igm Biosciences, Inc. Binding molecules with modified j-chain
US20170349660A1 (en) * 2016-06-01 2017-12-07 Xencor. Inc. Bispecific antibodies that bind cd123 and cd3
SG11202008343YA (en) * 2018-03-01 2020-09-29 Igm Biosciences Inc IgM Fc AND J-CHAIN MUTATIONS THAT AFFECT IgM SERUM HALF-LIFE

Similar Documents

Publication Publication Date Title
US11524991B2 (en) PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof
JP2022177090A5 (zh)
JP6702893B2 (ja) 多重特異的抗原結合タンパク質
JP6722189B2 (ja) 単量体Ｆｃドメイン
AU2016284871B2 (en) Multispecific NK engager proteins
JP2022137054A (ja) ＮＫｐ４６結合タンパク質の可変領域
TWI622597B (zh) 具有交叉結合區定向之雙重可變區類抗體結合蛋白
JP2019528683A5 (zh)
JP2017536829A5 (zh)
CA3131033A1 (en) Modified fc fragment, antibodies containing the same and use thereof
TW201803899A (zh) 三特異性和／或三價結合蛋白
JP2019530640A5 (zh)
WO2015197582A1 (en) Monomeric multispecific antigen binding proteins
WO2014144357A1 (en) Tetravalent bispecific antibodies
US20210253736A1 (en) Heterodimeric antibodies that bind fibroblast activation protein
US20220289856A1 (en) Multimeric bispecific anti-cd123 binding molecules and uses thereof
TWI754211B (zh) 新型雙特異性cd3/cd20多肽複合物
CN113874399A (zh) 抗ror1/抗cd3双特异性结合分子
CA3208781A1 (en) Multispecific antibodies having specificity for ror1 and cd3
WO2019101695A1 (en) Multispecific antigen binding proteins
JPWO2021034646A5 (zh)
EP4313312A1 (en) Multispecific proteins comprising an nkp46-binding site, a cancer antgienge binding site fused to a cytokine for nk cell engaging
US20220119525A1 (en) Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3
CN111971090A (zh) 双特异性egfr/cd16抗原结合蛋白
JP2022525261A (ja) ビスタ結合抗体およびその使用